Resource management is often the most overlooked aspect of R&D portfolio and project management. Despite its crucial role in ensuring project success, many organizations focus predominantly on project selection and prioritization, but neglect or defer addressing the complexities of allocating limited resources across multiple projects. This can lead to bottlenecks, delays and inefficiencies that not […]
Introduction As we anticipate the year ahead, several pharmaceutical industry trends are set to be redefined by the digital revolution. From data management and technological advancements in deriving insights to the integration of artificial intelligence (AI) and machine learning in healthcare and research, these advancements are poised to revolutionize the field. The global pharmaceutical market […]
In the dynamic domain of pharmaceutical research and development, data is emerging as a lifeline where new innovations are transforming our lives every day. The pharmaceutical industry captures an enormous amount of data throughout the drug development process. According to McKinsey, impact of advanced analytics will drive between 15% and 30% improvement of EBIDTA (Earnings […]
R&D funds in pharmaceuticals are scares, it is important that they be allocated wisely. Companies often find it difficult to decide on which resources to pursue or, at times even more significant which resources to retire or discontinue. Are you making these common mistakes? Guesstimates: Your next project or project phase is about to start, you hold a team meeting, and based […]
The COVID-19 pandemic has strained pharma and healthcare system, not just in India but worldwide. The demand and supply gap have exposed the vulnerabilities of the existing infrastructure of pharma ecosystem. The need of the hour is greater resilience and flexibility. Cloud technologies are gradually finding way in manufacturing, supply chain and delivery operations. With robust infrastructure […]
Digitization led to big data which by 2020 will have 44 trillion gigabytes of data. We are in a position where we have access to masses of data, but our ability to effectively use this data for competitive advantage is a constraint. The reason being most of this data is unstructured and scattered across multiple […]
